Abstract: Disclosed are dithio compounds that include a quenched fluorophore and a non-fluorophore peptide linked via a dithio bond to the fluorophore. The dithio compounds may be used in methods for detecting thiol-containing compounds or dithio-containing compounds. The dithio compounds also may be used as cellular probes where the peptide portion of the compounds targets the compounds to a specific cellular location.
Abstract: The present invention provides cysteine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.
Type:
Grant
Filed:
October 4, 2010
Date of Patent:
May 7, 2013
Assignees:
Marquette University, UWM Research Foundation, Inc.
Inventors:
James M. Cook, Edward Merle Johnson, II, David A. Baker, Wenyuan Yin
Abstract: The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.
Type:
Application
Filed:
May 7, 2012
Publication date:
August 30, 2012
Applicants:
UWM RESEARCH FOUNDATION, INC., MARQUETTE UNIVERSITY
Inventors:
James M. Cook, David A. Baker, Wenyuan Yin, Edward Merle Johnson, II
Abstract: Disclosed are passive lower limb prosthetic devices comprising at least a two degree of freedom mechanism and a network of compression springs.
Abstract: The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction. Exemplary prodrugs include the cysteine compound having the formula as well as cystine dimers thereof.
Type:
Grant
Filed:
February 9, 2009
Date of Patent:
May 8, 2012
Assignees:
Marquette University, UWM Research Foundation, Inc.
Inventors:
James M. Cook, David A. Baker, Wenyuan Yin, Edward Merle Johnson, II
Abstract: Disclosed herein are methods for improving performance of an anaerobic digester system. The methods typically include adding a culture comprising hydrogenotrophic methanogens to the system, otherwise referred to as bioaugmentation.
Abstract: Disclosed are drying methods for preserving cultures of methanogens and dried cultures obtained by the disclosed drying methods. The dried cultures of methanogens may be reconstituted and utilized to bioaugment anaerobic digester systems.
Abstract: Disclosed herein are magnetic storage devices and uses therefor. The devices comprise an injection pad and a nanowire extending from an outer edge of the injection pad. The injection pad and the nanowire of the disclosed magnetic storage devices have a geometry that is designed to optimize high density memory storage via low magnetic field domain wall shifting. The devices may be utilized, for example, for generating and storing magnetic domain walls for application in memory devices, sensor devices, and logic devices.
Abstract: The present invention provides cysteine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.
Type:
Application
Filed:
October 4, 2010
Publication date:
January 27, 2011
Applicants:
Marquette University, University of Wisconsin- Milwaukee
Inventors:
James M. Cook, David A. Baker, Edward Merle Johnson, III, Wenyuan Yin
Abstract: Disclosed are dithio compounds that include a quenched fluorophore and a non-fluorophore peptide linked via a dithio bond to the fluorophore. The dithio compounds may be used in methods for detecting thiol-containing compounds or dithio-containing compounds. The dithio compounds also may be used as cellular probes where the peptide portion of the compounds targets the compounds to a specific cellular location.
Abstract: Disclosed herein are compositions and methods for treating a psychiatric disorder or symptoms thereof in a patient. The compositions comprise a compound that modulates KCNQ (Kv7) potassium channel activity and the methods include administering an effective amount of the compound that modulates KCNQ (Kv7) potassium channel activity.
Abstract: Disclosed herein are methods related to drug development. The methods typically include steps whereby two chemical fragments are identified as binding to a target protein and subsequently the two chemical fragments are joined to create a new chemical entity that binds to the target protein.
Abstract: Disclosed herein are methods related to drug development. The methods typically include steps whereby an existing drug is modified to obtain a derivative form or whereby an analog of an existing drug is identified in order to obtain a new therapeutic agent that preferably has a higher efficacy and fewer side effects than the existing drug.
Abstract: The present invention provides cysteine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.
Type:
Grant
Filed:
August 11, 2008
Date of Patent:
November 9, 2010
Assignees:
Marquette University, University of Wisconsin - Milwaukee
Inventors:
James M. Cook, David A. Baker, Edward Merle Johnson, II, Wenyuan Yin
Abstract: Disclosed herein are dithio compounds that include at least one fluorophore. The compounds additionally may include a different fluorophore or a non-fluorophore. The dithio compounds may be used as reagents for detecting thiol-containing compounds.
Abstract: Phosphate-containing co-polymers useful for making denture bases, denture liners and tissue conditioners with phosphate anion-charged surfaces are disclosed. The phosphate anions enable the denture bases, denture liners and tissue conditioners to adsorb cationic antimicrobial molecules. Dentures, denture bases materials, denture liners and tissue conditioners made of the above co-polymers are also disclosed. Further disclosed are methods for synthesizing the co-polymer(s) and for making the denture bases, denture liners and tissue conditioners.
Type:
Grant
Filed:
September 26, 2007
Date of Patent:
August 24, 2010
Assignee:
Marquette University
Inventors:
Antony R. Periathamby, Andrew R. Dentino
Abstract: The present invention provides cysteine and cystine bioisosteres for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing such bioisosteres and methods of using the bioisosteres for treatment of schizophrenia and drug addiction.
Type:
Application
Filed:
April 16, 2009
Publication date:
February 25, 2010
Applicants:
Marquette University, University of Wisconsin - Milwaukee
Inventors:
James M. Cook, David A. Baker, Wenyuan Yin, Edward Merle Johnson, II
Abstract: Disclosed are assays useful for detecting kinase activity. The assays utilize thiol-reactive fluorescent reagents and include reacting a reaction mixture that contains an ATP analog such as ATP?S to form an ADP analog such as ADP?S if kinase activity is present in the reaction mixture. The ADP analog reacts with the thiol-reactive fluorescent reagent and the reagent exhibits a change in fluorescence, thereby indicating that kinase activity is present in the reaction mixture.